Cellogen Therapeutics is developing CAR-T cell therapies for blood cancers in India

Company Details Company Overview Founded 2021 Founders Dr Gaurav Kharya, Dr Tanveer Ahmad Headquarters New Delhi; manufacturing facility in Noida Sector Cell and gene therapy, oncology and blood disorders Funding Raised About $2 million (roughly ₹15 crore) from Natco Pharma for a 5.38% stake; ₹20 crore from Kotak Alternate Asset Managers, announced May 2026 Key Investors Natco Pharma, Kotak Alternate Asset Managers (Kotak Life Sciences Fund I) Clinical Partner Christian Medical College, Vellore